← SynDRA
T-817
SynDRA canonical compound SYN0039827 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | APP |
|---|
| Mechanism of action | beta amyloid inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- beta amyloid inhibitor
- APP INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Edonerpic
- J2.972.359A
- 1-(3-(2-(Benzo[b]thiophen-5-yl)ethoxy)propyl)azetidin-3-ol
- Edonerpic [INN]
- Edonerpic [WHO-DD]
- QY49O94S2W
- UNII-QY49O94S2W
- 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}azetidin-3-ol
- 1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol
- 3-Azetidinol, 1-(3-(2-benzo(b)thien-5-ylethoxy)propyl)-
- 3-Azetidinol, 1-[3-(2-benzo[b]thien-5-ylethoxy)propyl]-
- 1-(3-(2-(Benzo(b)thiophen-5-yl)ethoxy)propyl)azetidin-3-ol
- edonerpico
- edonerpicum
- 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol
- RefChem:136297
- MFCD28502068
- Edonerpic maleate
- Edonerpic [INN:WHO-DD]
- SCHEMBL27725
- SCHEMBL30574118
- HQNACSFBDBYLJP-UHFFFAOYSA-N
- EX-A4553
- BDBM50405511
- BDBM50559172
- AKOS027337120
- NS00069286
- P14964
- F504963
- 1-[3-[2-(benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol
- 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)-3-azetidinol
- 1-(3-[2-(1-benzothiophen-5-yl)ethoxy]propyl) azetidin-3-ol
- 1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl}-3-azetidinol
- T-817 maleate
- AKOS037515584
- HY-17631A
- 1-(3-(2-(Benzo(b)thiophene-5-yl)ethoxy)propyl)azetidine-3-ol maleate
- CS-8069
- GLXC-21835
Look up T-817 in the interactive SynDRA portal →